Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Hybrid vector" patented technology

Hybrid vectors are vector viruses that are genetically engineered to have qualities of more than one vector.

Multi-view remote sensing image fusion method

The invention discloses a multi-view remote sensing image fusion method, relates to the technical field of geographic information, and aims to solve the problem of low registration precision caused by limitation of registration of non-rigid transformation of an existing registration technology to ground surface fluctuation change or image multi-view change. The method comprises the steps of step 1, obtaining multiple groups of remote sensing images of different view angles in a same position through a satellite map or an unmanned aerial vehicle; step 2, extracting feature points of the multiple groups of the remote sensing images obtained in the step 1 by adopting a scale invariant feature transform algorithm to obtain a dot matrix (a) and a dot matrix (b); and step 3, registering the dot matrixes (a and b) in different states with a non-rigid dot matrix registration method based on global and local hybrid vectors and features, transforming a corresponding relationship of the remote sensing images obtained in the step 3 before and after view transformation by utilizing affine transformation, and outputting a registration result, so as to realize the fusion of the multi-view remote sensing images. The method is used for image fusion of the images during multi-view transformation.
Owner:YUNNAN NORMAL UNIV

Method for constructing fluorescence labeled rhizobia

InactiveCN103409406ASufficient and easily available raw materialsLow priceHybrid cell preparationBiotechnologyAlfalfa leaf
The invention discloses a method for improving conjugational transfer efficiency of fluorescent plasmid transfer of fluorescence labeling strains of rhizobia by taking sterilizing alfalfa leaves as triparental mating carriers instead of sterile filter membranes. The method can be used for efficiently constructing CFP (cyan fluorescent protein) gene labeled strains of rhizobia. The method specifically comprises the following steps of taking small and tender leaves of alfalfa, uniformly putting the leaves in a single layer in a culture dish after washing the leaves with distilled water, and sterilizing the leaves; taking out the leaves with a pair of sterile tweezers, sticking the leaves to the surface of TY culture media, and covering the culture dish; and using the leaves to replace microporous filter membranes in the triparental mating process to carry out mixed growing culture on donors, assistant bacteria and recipient bacteria. Compared with the microporous filter membranes as the mating carriers, the alfalfa leaves, as the mating carriers, can improve the conjugational transfer efficiency of the fluorescent plasmids by 8.4-11 times, and the difference is obvious. As the used raw materials are alfalfa plant leaves which are renewable and accessible, the method has the advantage that the raw materials are cheap and accessible, is simple and convenient to operate and is suitable for constructing the fluorescence labeling strains of rhizobia.
Owner:GANSU AGRI UNIV

Modified antibodies with human milk fat globule specificity and uses

An analogue peptide that comprises the variable regions of the light or heavy chains of an antibody of a first species selectively binding to a carcinoma antigen has 1 to 46 amino acids of the framework regions per chain substituted with amino acids such as those present in equivalent positions in antibodies of a species other than the first species, or fragments thereof comprising 1 to 3 variable region CDRs per chain and optionally flanking regions thereof of 1 to 10 or more amino acids, alone or with an N-terminal fragment of 1 to 10 or more amino acids, combinations or mixtures thereof. The polypeptide may also comprise an effector agent and/or be glycosylated, and is presented as a composition with a carrier. The analogue peptides are used in diagnostic kits for carcinomas and methods for in vivo imaging and treating a primary or metastasized carcinoma, and in vitro diagnosing a carcinoma, ex vivo purging neoplastic cells from a biological fluid. RNAs and DNAs encode the analogue peptide, and a hybrid vector carrying the nucleotides and transfected cells express the peptides and a method produces the analogue peptide. An anti-idiotype polypeptide comprises polyclonal antibodies raised against an anti-carcinoma antibody or the analogue peptide of this invention, monoclonal antibodies thereof, Fab, Fab′, (Fab′)2, CDR, variable region, or analogues or fragments thereof, combinations thereof with an oligopeptide comprising a TRP trimer, tandem repeats thereof, or combination or mixtures thereof. An anti-idiotype hybrid polypeptide with an effector agent and the anti-idiotype polypeptide, an anti-carcinoma vaccine, an anti-carcinoma vaccination kit, a method of vaccinating against carcinoma and a method of lowering the serum concentration of a circulating antibody or polypeptide are provided.
Owner:US DEPT OF HEALTH & HUMAN SERVICES

PGADT7-In vector applicable to In-Fusion cloning as well as construction and use methods of pGADT7-In vector

The invention belongs to the technical field of biology, and particularly relates to a pGADT7-In vector applicable to In-Fusion cloning as well as construction and use methods of the pGADT7-In vector.A multiple cloning site of pGADT7 is transformed with a site-directed mutagenesis technology, the pGADT7-In vector is obtained, after pGBKT7 vector and the pGADT7-In vector are subjected to enzyme digestion with EcoRI, formed tail ends contain the same sequence with length being 15 bp or longer, and further, vector construction is performed with the In-Fusion technology; only one pair of primersis required for construction of a bait vector or a prey vector of a given gene, and one-time PCR is performed; an obtained PCR product is subjected to an In-Fusion reaction with pGBKT7 or pGADT7, escherichia coli is transformed, LB flat plates with different resistance are coated with an obtained product, identification is performed by bacterial colony or bacterial liquid PCR, and construction ofthe bait vector or the prey vector is completed easily, rapidly and efficiently. With application of the pGADT7-In vector and the vector construction method to construction of a yeast two-hybrid vector, experimental cycle is greatly shortened, experimental cost is reduced, and success rate is increased.
Owner:ZHOUKOU NORMAL UNIV

Processes and products with modified antibodies of human milk fat globule specificity

An analogue peptide that comprises the variable regions of the light or heavy chains of an antibody of a first species selectively binding to a carcinoma antigen has 1 to 46 amino acids of the framework regions per chain substituted with amino acids such as those present in equivalent positions in antibodies of a species other than the first species, or fragments thereof comprising 1 to 3 variable region CDRs per chain and optionally flanking regions thereof of 1 to 10 or more amino acids, alone or with an N-terminal fragment of 1 to 10 or more amino acids, combinations or mixtures thereof. The polypeptide may also comprise an effector agent and / or be glycosylated, and is presented as a composition with a carrier. The analogue peptides are used in diagnostic kits for carcinomas and methods for in vivo imaging and treating a primary or metastasized carcinoma, and in vitro diagnosing a carcinoma, ex vivo purging neoplastic cells from a biological fluid. RNAs and DNAs encode the analogue peptide, and a hybrid vector carrying the nucleotides and transfected cells express the peptides and a method produces the analogue peptide. An anti-idiotype polypeptide comprises polyclonal antibodies raised against an anti-carcinoma antibody or the analogue peptide of this invention, monoclonal antibodies thereof, Fab, Fab′, (Fab′)2, CDR, variable region, or analogues or fragments thereof, combinations thereof with an oligopeptide comprising a TRP trimer, tandem repeats thereof, or combination or mixtures thereof. An anti-idiotype hybrid polypeptide with an effector agent and the anti-idiotype polypeptide, an anti-carcinoma vaccine, an anti-carcinoma vaccination kit, a method of vaccinating against carcinoma and a method of lowering the serum concentration of a circulating antibody or polypeptide are provided.
Owner:DO COUTO FERNANDO +3

Recombinant vector for high-throughput yeast two-hybrid technology and method for large-scale screening of interacting proteins

The invention discloses a related recombinant vector used for yeast two-hybrid and a yeast two-hybrid method for large-scale screening interacting protein using a high-flux sequencing technology. The method depends on a peculiar integrative function of an integrase Integrase phiC31(En), and by conducting transformation on a traditional yeast two-hybrid vector, the vector is capable of conducting organic combination with the high-flux sequencing technology, and thus that hundreds of bait protein can simultaneously conduct screening work on Prey protein library can be realized. The method comprises the steps of inserting the integrase and a specially recognized nucleotide sequence into a vector of a Matchmaker GAL4 system, making the recombinant vector enter into the same yeast cell through the yeast two-hybrid method, using the integrase to play a role in conducting specific orientational rearrangement on the specially recognized nucleotide sequence and a nucleotide sequence closely adjacent to the specially recognized nucleotide sequence so as to make two recombinant vectors combine into a combined vector, at this time the Prey protein and the bait protein are orientationally connected into one new section of sequence on the combined vector. Through amplification and high high-flux sequencing, the recombinant vector can conduct economic and efficient screening on interacting proteins and construct a comprehensive network atlas for interactions between the proteins.
Owner:HUAZHONG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products